Samar Bishtawi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cardiovascular disease is the most common cause for mortality and morbidity in the developed world; its risk is inversely related to the high-density lipoprotein (HDL) cholesterol levels. Therefore, there is a great interest in developing new cholesteryl ester transfer protein (CETP) inhibitors capable of raising HDL as a novel approach for the prevention(More)
  • 1